Ligand Pharmaceuticals reported $298K in Interest Income for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Income Change
Arrowhead Research ARWR:US USD 1.58M 343K
Baxter International BAX:US USD 5M 1000K
Eli Lilly LLY:US USD 20.1M 9.9M
Endo International ENDP:US USD 178K 31K
Harsco HSC:US USD 952K 259K
Intrexon XON:US USD 56K 19K
Karyopharm Therapeutics KPTI:US USD 658K 365K
Pacira PCRX:US USD 1.23M 982K
Pfizer PFE:US USD 70M 40M
Rigel Pharmaceuticals RIGL:US USD 192K 150K
Sangamo BioSciences SGMO:US USD 1.77M 874K
Veracyte VCYT:US USD 573K 361K